T2	Participants 145 202	subjects infected with human immunodeficiency virus (HIV)
T3	Participants 235 260	HIV-seropositive patients
T4	Participants 551 651	Six HIV-seropositive subjects with elevated amounts of TNF-alpha in plasma at least at two occasions
T1	Participants 26 69	HIV seropositive subjects with elevated TNF
T5	Participants 1228 1236	patients
